Ticker: CCJ

Cameco

Energy Energy Uranium
Price 97.42
Reco Sell Potential 46 Risk 69 Updated 2026-09-10

Forecast impact

positive
Target +29.5% target fill 77.2%
Reaction D5 -0.76% · D10 +4.10% market trust
Impact Potential +3 · Risk -1 valid until 2026-09-11

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Cameco Corporation is a leading player in the energy sector, primarily engaged in the exploration, mining, and production of uranium. The company operates through various segments, including uranium production and fuel services. Its core products include uranium concentrate and conversion services, which are essential for nuclear power generation. Major revenue sources stem from long-term contracts with utilities and spot market sales, positioning Cameco as a significant supplier in the global nuclear energy market.

Investment Profile

The investment profile of Cameco is more aligned with value investors, given its current market position and dividend yield. The stock exhibits characteristics that may appeal to those seeking stability rather than aggressive growth. However, the recent decline in revenue and elevated risk factors suggest a cautious approach. The stock may be suitable for medium to long-term horizons, with moderate liquidity considerations.

Fundamental metrics (experimental) Updated: 2026-09-05
EPS (TTM) — earnings per share for the last 12 months, $
0.82
Revenue QoQ — quarter-over-quarter revenue growth
-3.7%
EPS surprise
-50.0%
20d volatility
2.8%
Dividend yield
0.2%
last ex-date
2025-12-01
AI recommendation changes
Date Before After Reason
2026-09-04 Hold Sell Weak fundamentals and negative momentum raise concerns.
2026-08-27 Sell Hold Weak fundamentals offset recent price momentum.
2026-08-20 Hold Sell Weak fundamentals and negative momentum raise concerns.
Analyst forecasts
Date Analyst Action Target Price Then
2026-09-03 Jefferies Update — → 138 96.38
2026-08-12 Truist Financial Target Raised 129 → 130 99.31
2026-08-04 Barclays Target Lowered 104 → 97 89.72
News Page 1 of 1
Rhythm Pharmaceuticals Sonida Senior Living Ford Motor Company Rivian Anheuser-Busch InBev Cameco Mobileye Global Williams-Sonoma General Motors

Analysts Piper Sandler upgrade Rivian (RIVN) and Mobileye (MBLY) to Overweight, citing strong demand outlooks

Recent analyst upgrades and initiations across various sectors indicate a positive outlook for several companies, including Rivian, Mobileye, and Williams-Sonoma, suggesting potential investment opportunities for investors.